Human Immunodeficiency Virus/Hepatitis C Virus Coinfection in Spain: Prevalence and Patient Characteristics

نویسندگان

  • Juan Berenguer
  • Antonio Rivero
  • Inmaculada Jarrín
  • María J. Núñez
  • María J. Vivancos
  • Manel Crespo
  • María J. Téllez
  • Pere Domingo
  • José A. Iribarren
  • Arturo Artero
  • Manuel Márquez
  • Ignacio Santos
  • Javier Moreno
  • Marta Montero
  • Juan González-García
  • L. Pérez-Latorre
  • P. Miralles
  • J.C. López
  • F. Parras
  • B. Padilla
  • T. Aldámiz
  • A. Carrero
  • C. Díez
  • F. Tejerina
  • J. Berenguer
  • M.J. Núñez
  • F. Arnalich
  • J.R. Arribas
  • J.I. Bernardino
  • J. González-García
  • V. Hontañón
  • M.L. Martín-Carbonero
  • R. Montejano
  • M.L. Montes
  • V. Moreno
  • I. Pérez-Valero
  • C. Navarro
  • E. Valencia
  • Francisca Cuenca
  • A. Rivero-Román
  • I. Jarrín
  • M.J. Vivancos
  • S. Moreno
  • A. Moreno
  • J.L. Casado
  • M.J. Pérez-Elías
  • C. Quereda
  • A. Torrella
  • J. Navarro
  • N. Ramos
  • M. Crespo
  • M. Rodrigo
  • V. Estrada
  • J. Vergas
  • M.J. Téllez
  • J. Muñoz
  • M. Gutiérrez
  • G. Mateo
  • J.M. Guardiola
  • P. Domingo
  • M. Ibarguren
  • M.P. Carmona
  • F. Rodríguez-Arrondo
  • M.A. Goenaga
  • H. Azkune
  • M.A. Von Wichmann
  • J.A. Iribarren
  • J. Carmena
  • A. Artero
  • J. Ruiz
  • E. Nuño
  • R. Palacios
  • J. Santos
  • M. Márquez
  • J. Sanz
  • I. Santos
  • J. Moreno
  • P. Arazo
  • M. Montero
  • M. Tasias
  • S. Cuellar
  • E. Calabuig
  • M. Blanes
  • J. Fernández
  • J. López-Aldeguer
  • M. Salavert
  • A. Hernando
  • L. Domínguez
  • O. Bisbal
  • M. De Lagarde
  • M. Matarranz
  • Rafael Rubio
  • F. Pulido
  • C. García
  • C. Armiñanzas
  • S. Echevarría
  • M. Gutiérrez-Cuadra
  • C. Fariñas
  • L. Giner
  • S. Reus
  • E. Merino
  • V. Boix
  • D. Torrús
  • I. Portilla
  • M. Pampliega
  • M. Díez
  • I. Egea
  • J. Portilla
  • O.L. Ferrero
  • S. Ibarra
  • I. López
  • M. de la Peña
  • Z. Zubero
  • J. Baraia
  • J. de Miguel
  • A. Arranz
  • E. Casas
  • A. Ferrer
  • M.J. Galindo
  • L. García
  • L. Pérez
  • J.A. Oteo
  • M. Velasco
  • L. Moreno
  • R. Hervás
  • J.E. Losa
  • D. Vinuesa
  • L. Muñoz
  • J. Hernández-Quero
  • S. Veloso
  • J. Peraire
  • C. Viladés
  • M. Vargas
  • A. Castellano
  • F. Vidal
  • R. Silvariño
  • A.J. Orti
  • E. Chamarro
  • C. Escrig
  • P. Geijo
  • A. Chocarro
  • C. Rodríguez
  • T. Puerta
  • M. Raposo
  • M. Vera
  • J. Del Romero
  • J. Bisbe
  • C. Cifuentes
  • R. Teira
  • J. Vilaró
  • A. Vegas
  • A. Cano
  • A. Alcaráz
  • A. Muñoz
  • E. Bernal
  • M. Campoamor
  • M.J. Tuya
  • A. Gimeno
  • C. Montero
  • S. Arponen
  • L. Force
  • P. Barrufet
  • G. Gaspar
  • G. Alonso
  • C. Toledo
  • G. Lara
  • I. Fernández
  • M.C. Esteban
چکیده

Background.  The purpose of this study was to assess the prevalence of anti-hepatitis C virus (HCV) antibodies (Abs) and active HCV infection in human immunodeficiency virus (HIV)-infected (HIV+) patients in Spain in 2015. This was a cross-sectional study. Methods.  The study was performed in 41 centers in 2015. Sample size was estimated for an accuracy of 2%, the number of patients from each hospital was determined by proportional allocation, and patients were selected using simple random sampling. Results.  The reference population was 35 791 patients, and the sample size was 1867 patients. Hepatitis C virus serostatus was known in 1843 patients (98.7%). Hepatitis C virus-Abs were detected in 695 patients (37.7%), in whom the main route of HIV acquisition was injection drug use (75.4%). Of these 695 patients, 402 had HCV RNA, 170 had had a sustained viral response (SVR) after anti-HCV therapy, and 102 cleared HCV spontaneously. Hepatitis C virus-ribonucleic acid results were unknown in 21 cases. Genotype distribution (known in 367 patients) was 1a in 143 patients (39.0%), 4 in 90 (24.5%) patients, 1b in 69 (18.8%) patients, 3 in 57 (15.5%) patients, 2 in 5 (1.4%) patients, and mixed in 3 (0.8%) patients. Liver cirrhosis was present in 93 patients (23.1%) with active HCV infection and in 39 (22.9%) patients with SVR after anti-HCV therapy. Conclusions.  The prevalence of HCV-Abs and active HCV infection in HIV+ patients in Spain is 37.7% and 22.1%, respectively; these figures are significantly lower than those recorded in 2002 and 2009. The predominant genotypes in patients with active HCV infection were 1a and 4. A high percentage of patients had cirrhosis. Cirrhosis is also common in patients with SVR after anti-HCV therapy.

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

The Prevalence of Hepatitis B, Hepatitis C, and Human Immunodeficiency Virus Infections among β-thalassemia Major: A Multicenter Survey in Lorestan, West of Iran

Background: Although regular frequent blood transfusion improves overall survival of multi-transfused patients like β-thalassemic ones, it carries a definite risk of infection with blood-borne viruses such as viral hepatitis. This study was done to determine seropositivity of hepatitis B virus (HBV), hepatitis C virus (HCV), and Human Immunedeficiency Virus (HIV) infections among β-th...

متن کامل

Seroprevalence of Human Immunodificiency Virus (HIV) and Hepatitis C Infection In Hemophilic Patients In Iran

  Background and Objective: Although transfusion therapy has lead to great improvement in longevity for hemophiliacs, but there have been tragic setbacks especially from transmission of human immunodeficiency virus (HIV) and hepatitis C virus (HCV) .HIV was reported to increase the rate of HCV-related liver failure by 4.2 times. In this study, we aimed to determine the seroprevalence of HIV an...

متن کامل

Prevalence of Hepatitis B virus, Hepatitis C virus and human immunodeficiency virus infections among patients candidate for orthopedic trauma surgeries

Background: Infectious diseases are major public health problems, among which blood-borne ones are the most important infections. Patients who undergo orthopedic surgery are at higher risk of transmitting infectious diseases from and to others, due to repeated blood examinations and injection, drains secretion and receiving blood products. Accordingly, in this study we determined prevalence of ...

متن کامل

The Prevalence of Blood-Borne Viral Infection (HBV, HCV, HIV) among Hemophilia Patients in Hamedan Province of Iran

Background: Hemophilia A and B are the most frequent congenital coagulation disorders. This study was conducted to determine the prevalence of hepatitis B, C and human immunodeficiency viruses among hemophilic patients in Hamadan, Iran. Patients and Methods: In this study, patients with hemophilia A and B treated in Hamedan Hemophilia Center, Hamedan, Iran, were screened for hepatitis B, C and...

متن کامل

The Association between the Prevalence of Transfusion Transmitted Infections and Characteristics of Infected Blood Donors in Kerman, Iran

Background:Nowadays, one of the main challenges of the blood transfusion organization is the procurement, distribution, and monitoring of the appropriate use of blood and its products. Therefore, the aim of this study was to investigate the prevalence of Transfusion Transmitted Infections (TTIs) including human immunodeficiency virus (HIV+), hepatitis B virus (HBV+), and hepati...

متن کامل

The Prevalence of Transfusion Transmitted Infections among Blood Donors in Kerman, Iran

Background & Aims: Today, an important challenge of the Blood Transfusion Organization is the preparation, distribution, and monitoring of the appropriate use of blood and blood products. Therefore, estimation of the prevalence of transfusion transmitted infections (TTIs) and efficiency of appropriate screening methods is essential. The purpose of the present study was the det...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:

دوره 3  شماره 

صفحات  -

تاریخ انتشار 2016